Nanjing Gator Meditech Company, Ltd.;Iwanowicz, Edwin, J.
发明人:
IWANOWICZ, Edwin, J.
申请号：
EP17840404
公开号：
EP3496720A4
申请日:
2017.08.14
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
The present invention provides, in part, novel compounds and pharmaceutically acceptable salts capable of modulating the activity of kinases, including Akt, ERK and MEK. Such modulation affects biological functions, for example, by inhibiting cell proliferation and/or inducing apoptosis. Also provided are pharmaceutical compositions and medicaments, comprising the compounds or salts of the invention, alone or in combination with other therapeutic agents or palliative agents.
